{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:14:15Z","timestamp":1777698855994,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T00:00:00Z","timestamp":1441584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11010-015-2562-4","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T14:20:20Z","timestamp":1441635620000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells"],"prefix":"10.1007","volume":"410","author":[{"given":"Fredrick J.","family":"Bohanon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anesh","family":"Prasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhashiva J.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetha L.","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Rastellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi S.","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,7]]},"reference":[{"key":"2562_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2014.02.015","volume":"548","author":"E Novo","year":"2014","unstructured":"Novo E, Cannito S, Paternostro C, Bocca C, Miglietta A, Parola M (2014) Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys 548:20\u201337. doi: 10.1016\/j.abb.2014.02.015","journal-title":"Arch Biochem Biophys"},{"key":"2562_CR2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbrc.2014.03.037","volume":"446","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Ghazwani M, Li J, Sun M, Stolz DB, He F, Fan J, Xie W, Li S (2014) MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase. Biochem Biophys Res Commun 446:940\u2013944. doi: 10.1016\/j.bbrc.2014.03.037","journal-title":"Biochem Biophys Res Commun"},{"key":"2562_CR3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","volume":"21","author":"RC Benyon","year":"2001","unstructured":"Benyon RC, Arthur MJ (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21:373\u2013384. doi: 10.1055\/s-2001-17552","journal-title":"Semin Liver Dis"},{"issue":"Suppl 2","key":"2562_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1440-1746.2011.07001.x","volume":"27","author":"K Asahina","year":"2012","unstructured":"Asahina K (2012) Hepatic stellate cell progenitor cells. J Gastroenterol Hepatol 27(Suppl 2):80\u201384. doi: 10.1111\/j.1440-1746.2011.07001.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2562_CR5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbadis.2013.02.019","volume":"1832","author":"S Lemoinne","year":"2013","unstructured":"Lemoinne S, Cadoret A, El Mourabit H, Thabut D, Housset C (2013) Origins and functions of liver myofibroblasts. Biochim Biophys Acta 1832:948\u2013954. doi: 10.1016\/j.bbadis.2013.02.019","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 2","key":"2562_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1440-1746.2011.07022.x","volume":"27","author":"H Tsukamoto","year":"2012","unstructured":"Tsukamoto H, Zhu NL, Wang J, Asahina K, Machida K (2012) Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J Gastroenterol Hepatol 27(Suppl 2):94\u201398. doi: 10.1111\/j.1440-1746.2011.07022.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2562_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","volume":"55","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang Z, Kwong SQ, Lui EL, Friedman SL, Li FR, Lam RW, Zhang GC, Zhang H, Ye T (2011) Inhibition of PDGF, TGF-\u03b2, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol 55:612\u2013625. doi: 10.1016\/j.jhep.2010.11.035","journal-title":"J Hepatol"},{"key":"2562_CR8","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.bcp.2004.08.022","volume":"68","author":"SH Lee","year":"2004","unstructured":"Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH (2004) Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol 68:2367\u20132378. doi: 10.1016\/j.bcp.2004.08.022","journal-title":"Biochem Pharmacol"},{"key":"2562_CR9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.22637","volume":"49","author":"GA Ramm","year":"2009","unstructured":"Ramm GA, Shepherd RW, Hoskins AC, Greco SA, Ney AD, Pereira TN, Bridle KR, Doecke JD, Meikle PJ, Turlin B, Lewindon PJ (2009) Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 49:533\u2013544. doi: 10.1002\/hep.22637","journal-title":"Hepatology"},{"key":"2562_CR10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.immuni.2006.11.011","volume":"26","author":"F Winau","year":"2007","unstructured":"Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26:117\u2013129. doi: 10.1016\/j.immuni.2006.11.011","journal-title":"Immunity"},{"key":"2562_CR11","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Kim YO (2013) Evolving therapies for liver fibrosis. J Clin Invest 123:1887\u20131901. doi: 10.1172\/JCI66028","journal-title":"J Clin Invest"},{"key":"2562_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jss.2014.03.036","volume":"190","author":"FJ Bohanon","year":"2014","unstructured":"Bohanon FJ, Wang X, Ding C, Ding Y, Radhakrishnan GL, Rastellini C, Zhou J, Radhakrishnan RS (2014) Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis. J Surg Res 190:55\u201363. doi: 10.1016\/j.jss.2014.03.036","journal-title":"J Surg Res"},{"key":"2562_CR13","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1021\/jm401248x","volume":"56","author":"C Ding","year":"2013","unstructured":"Ding C, Zhang Y, Chen H, Yang Z, Wild C, Ye N, Ester CD, Xiong A, White MA, Shen Q, Zhou J (2013) Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis. J Med Chem 56:8814\u20138825. doi: 10.1021\/jm401248x","journal-title":"J Med Chem"},{"key":"2562_CR14","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ol4015865","volume":"15","author":"C Ding","year":"2013","unstructured":"Ding C, Zhang Y, Chen H, Wild C, Wang T, White MA, Shen Q, Zhou J (2013) Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position. Org Lett 15:3718\u20133721. doi: 10.1021\/ol4015865","journal-title":"Org Lett"},{"key":"2562_CR15","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1021\/jm400367n","volume":"56","author":"C Ding","year":"2013","unstructured":"Ding C, Zhang Y, Chen H, Yang Z, Wild C, Chu L, Liu H, Shen Q, Zhou J (2013) Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility. J Med Chem 56:5048\u20135058. doi: 10.1021\/jm400367n","journal-title":"J Med Chem"},{"key":"2562_CR16","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1039\/C4OB01040J","volume":"12","author":"C Ding","year":"2014","unstructured":"Ding C, Wang L, Chen H, Wild C, Ye N, Ding Y, Wang T, White MA, Shen Q, Zhou J (2014) ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids. Org Biomol Chem 12:8442\u20138452. doi: 10.1039\/c4ob01040j","journal-title":"Org Biomol Chem"},{"key":"2562_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"2562_CR18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02626182","volume":"25","author":"JH Kelly","year":"1989","unstructured":"Kelly JH, Darlington GJ (1989) Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2. In Vitro Cell Dev Biol 25:217\u2013222","journal-title":"In Vitro Cell Dev Biol"},{"key":"2562_CR19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/bp034301z","volume":"20","author":"B David","year":"2004","unstructured":"David B, Dufresne M, Nagel MD, Legallais C (2004) In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor. Biotechnol Prog 20:1204\u20131212. doi: 10.1021\/bp034301z","journal-title":"Biotechnol Prog"},{"key":"2562_CR20","first-page":"147","volume":"120","author":"FH Sarkar","year":"2006","unstructured":"Sarkar FH, Li Y (2006) Markers of apoptosis. Methods Mol Med 120:147\u2013160","journal-title":"Methods Mol Med"},{"key":"2562_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10616-013-9565-3","volume":"66","author":"S Fujisawa","year":"2014","unstructured":"Fujisawa S, Romin Y, Barlas A, Petrovic LM, Turkekul M, Fan N, Xu K, Garcia AR, Monette S, Klimstra DS, Erinjeri JP, Solomon SB, Manova-Todorova K, Sofocleous CT (2014) Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases. Cytotechnology 66:259\u2013273. doi: 10.1007\/s10616-013-9565-3","journal-title":"Cytotechnology"},{"key":"2562_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fphys.2012.00053","volume":"3","author":"K Yoshida","year":"2012","unstructured":"Yoshida K, Matsuzaki K (2012) Differential regulation of TGF-\u03b2\/Smad Signaling in hepatic stellate cells between acute and chronic liver injuries. Front Physiol 3:53. doi: 10.3389\/fphys.2012.00053","journal-title":"Front Physiol"},{"key":"2562_CR23","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.onc.1204252","volume":"20","author":"WR Taylor","year":"2001","unstructured":"Taylor WR, Stark GR (2001) Regulation of the G2\/M transition by p53. Oncogene 20:1803\u20131815. doi: 10.1038\/sj.onc.1204252","journal-title":"Oncogene"},{"key":"2562_CR24","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1091\/mbc.E03-12-0871","volume":"15","author":"FB Charrier-Savournin","year":"2004","unstructured":"Charrier-Savournin FB, Ch\u00e2teau MT, Gire V, Sedivy J, Piette J, Dulic V (2004) p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell 15:3965\u20133976. doi: 10.1091\/mbc.E03-12-0871","journal-title":"Mol Biol Cell"},{"key":"2562_CR25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1745-7254.2007.00588.x","volume":"28","author":"Q Cui","year":"2007","unstructured":"Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, Ikejima T (2007) P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin 28:1057\u20131066. doi: 10.1111\/j.1745-7254.2007.00588.x","journal-title":"Acta Pharmacol Sin"},{"key":"2562_CR26","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.2741\/3423","volume":"14","author":"K Matsuzaki","year":"2009","unstructured":"Matsuzaki K (2009) Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci (Landmark Ed) 14:2923\u20132934","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2562_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1359-6101(99)00026-X","volume":"11","author":"KM Mulder","year":"2000","unstructured":"Mulder KM (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11:23\u201335","journal-title":"Cytokine Growth Factor Rev"},{"key":"2562_CR28","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/j.1745-7254.2006.00440.x","volume":"27","author":"W Xu","year":"2006","unstructured":"Xu W, Sun J, Zhang TT, Ma B, Cui SM, Chen DW, He ZG (2006) Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma. Acta Pharmacol Sin 27:1642\u20131646. doi: 10.1111\/j.1745-7254.2006.00440.x","journal-title":"Acta Pharmacol Sin"},{"key":"2562_CR29","first-page":"139","volume":"40","author":"G Chen","year":"2012","unstructured":"Chen G, Wang K, Yang BY, Tang B, Chen JX, Hua ZC (2012) Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells. Int J Oncol 40:139\u2013147. doi: 10.3892\/ijo.2011.1210","journal-title":"Int J Oncol"},{"key":"2562_CR30","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1248\/bpb.27.1527","volume":"27","author":"CL Zhang","year":"2004","unstructured":"Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T (2004) Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929. Biol Pharm Bull 27:1527\u20131531","journal-title":"Biol Pharm Bull"},{"key":"2562_CR31","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2006-06-032250","volume":"109","author":"GB Zhou","year":"2007","unstructured":"Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J, Zhang FX, Weng XQ, Shen ZX, Chen J, Gu LJ, Yan M, Zhang DE, Chen SJ, Wang ZY, Chen Z (2007) Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood 109:3441\u20133450. doi: 10.1182\/blood-2006-06-032250","journal-title":"Blood"},{"key":"2562_CR32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2011.04.006","volume":"411","author":"S Li","year":"2011","unstructured":"Li S, Liu Y, Liu T, Zhao L, Zhao J, Feng N (2011) Development and in vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique. Int J Pharm 411:172\u2013177. doi: 10.1016\/j.ijpharm.2011.04.006","journal-title":"Int J Pharm"},{"key":"2562_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11655-013-1437-3","volume":"19","author":"W Tian","year":"2013","unstructured":"Tian W, Chen SY (2013) Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin. Chin J Integr Med 19:315\u2013320. doi: 10.1007\/s11655-013-1437-3","journal-title":"Chin J Integr Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2562-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-015-2562-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2562-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:15:48Z","timestamp":1559355348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-015-2562-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,7]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2562"],"URL":"https:\/\/doi.org\/10.1007\/s11010-015-2562-4","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,7]]}}}